Eli Lilly & Co. (LLY)
1038.40
+5.43
(+0.53%)
USD |
NYSE |
Jan 16, 16:00
1036.00
-2.40
(-0.23%)
Pre-Market: 20:00
Eli Lilly Market Cap: 929.39B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.92B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 3.834B |
| Moderna, Inc. | 16.34B |
Market Cap Related Metrics
| PE Ratio | 51.36 |
| PS Ratio | 15.93 |
| PEG Ratio | 0.4238 |
| Price to Book Value | 39.06 |
| Price to Free Cash Flow | 147.08 |
| Price | 1038.40 |
| Earnings Yield | 1.95% |
| PEGY Ratio | 0.4218 |
| Operating PE Ratio | 35.87 |
| Normalized PE Ratio | 45.99 |